Trial Profile

The Effect of Short Term Amiodarone Treatment on Success Rate and Quality of Life After Catheter Ablation for Atrial Fibrillation.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 11 Sep 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Amiodarone (Primary)
Indications Atrial fibrillation
Focus Therapeutic Use
Acronyms AMIO-CAT

Most Recent Events

24 Jul 2017 Results (n=102) of subpopulation assessing mid-regional pro-atrial natriuretic peptide and N-terminal pro brain natriuretic peptide in patients undergoing ablation for atrial fibrillation, published in the American Journal of Cardiology.
21 Aug 2013 Planned end date changed from 1 Nov 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
21 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com